Trading Update

NMT Group PLC
30 August 2002


30 August 2002

                                 NMT Group PLC
                                 Trading Update

    Strategy focuses on Pharmaceuticals, Distribution and Licensing Partners


NMT Group PLC, the manufacturer of safe needle medical devices, announced today
that it is to focus its core activities on supplying global pharmaceutical
companies with 'safer needle devices' in the field of drug delivery, whilst
increasing its activities to seek distribution and licensing partners for its
retractable needle technology in the US hospital market.

Acute care hospital sales have not grown at the levels originally envisaged, due
to the continued delayed impact of the US Needlestick Safety and Prevention Act
on hospital procurement practices and dominance of global safety companies in
medical device distribution. As a direct result, NMT will significantly reduce
its sales and marketing efforts in traditional healthcare markets.  This will
have some impact on earnings in 2002, which will be below market expectations,
but will reduce fixed costs and cash outflow in 2003.

The Company is already in the process of fulfilling a material order to supply
safety syringes to a major pharmaceutical company.  NMT believes that growth can
be most quickly realised by focusing its resources on the pharmaceutical sector.
The Group is actively pursuing supply arrangements with global pharmaceutical
companies who recognise the importance of providing safe needle technology.

Within traditional healthcare markets, NMT will continue to actively support the
existing customer base through its current distributor sales network.

The strategy to develop pharmaceutical opportunities, support existing acute
care customers and distributor relationships will allow NMT to efficiently
manage its resources whilst developing a cash generative business.

Commenting, Roy Smith, Chief Executive, said:

'NMT has a strong cash position and the strategy of focusing our efforts on both
partnerships with pharmaceutical companies and licensing and distribution
agreements in the hospital sector will ensure that we make the best use of our
resources and deliver a cash generative business to shareholders.'

The Group is due to announce its interim results on Tuesday 24 September 2002.



Enquiries:

NMT Group PLC
Roy Smith, Chief Executive Officer                 Tel: [phone]
Gerard Cassels, Finance Director                   Tel: [phone]

Financial Dynamics                                 Tel: [phone]
Fiona Noblet




                      This information is provided by RNS
            The company news service from the London Stock Exchange